Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients
Authors' conclusion
Our study identifies independent predictors of early and late cardiotoxicity, including demographic data, cardiovascular risk factors, history of cardiovascular disease, and oncologic history.
Study context
- Population
- Patients aged ≥15 years with haematologic malignancies undergoing allogeneic haematopoietic stem cell transplantation (alloHSCT), 2011–2020
- Participants
- 1,027 patients
- Outcome
- Cardiotoxicity:
- CV death
- HF
- Rhythm/conduction disorders
- Acute arterial events
- VTE
- Myopericarditis
Methodological detailssingle-centre, consecutive patients
- Single-centre
- Consecutive patients
Main finding
As reported in the abstract
Cardiotoxicity · median (IQR) follow-up 4 (1-7) years
Patients experiencing cardiotoxicity
30%
Median (IQR) time to first event
8 months
3–17
Observational data: associations, not effects.
Original publication
Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients. Eur J Prev Cardiol. Published 30 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →